Morgan Stanley Finance LLC has recently filed a new pricing supplement for its structured investments, which could reshape its approach to attracting investors. This filing, dated November 12, 2026, signals the company's commitment to offering innovative financial products in a competitive market.
The significance of this update lies in its potential to enhance Morgan Stanley's product offerings, particularly in the structured investments segment. As the financial services industry evolves, firms like Morgan Stanley must continuously adapt to meet investor demands and market trends.
Background
Morgan Stanley Finance LLC operates within the SIC category of Security Brokers, Dealers & Flotation Companies (SIC 6211). The company is incorporated in Delaware and has its headquarters at 1585 Broadway, New York, NY. It is a subsidiary of Morgan Stanley, a prominent player in the financial services industry.
What the Filing Says
The filing includes details about the new structured investment product, identified as Pricing Supplement No. 19,992. It describes the securities as "Contingent Income Memory Buffered Auto-Callable Securities with Downside Factor due November 24, 2027," which are based on the performance of NVIDIA Corporation's common stock. The securities are fully and unconditionally guaranteed by Morgan Stanley.
Impact
This new offering may attract a range of investors looking for innovative investment solutions. It emphasizes the risks associated with these securities, including the potential loss of principal and the lack of guaranteed interest payments. Investors must be prepared to accept the inherent risks of structured investments, which could influence their decisions moving forward.
What's Next
Following this filing, Morgan Stanley Finance LLC may continue to issue additional pricing supplements or related documents as part of its ongoing strategy to enhance its product offerings. However, the filing does not specify any immediate next steps.
Source: SEC Accession Number 0001839882-26-056226
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










